702 related articles for article (PubMed ID: 20844331)
21. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; Kluin J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2006; 82(6):1638-44. PubMed ID: 16879035
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I
Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516
[TBL] [Abstract][Full Text] [Related]
23. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
Dysart JS; Singh G; Patterson MS
Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385
[TBL] [Abstract][Full Text] [Related]
24. Monitoring PDT by means of superficial reflectance spectroscopy.
Amelink A; van der Ploeg van den Heuvel A; de Wolf WJ; Robinson DJ; Sterenborg HJ
J Photochem Photobiol B; 2005 Jun; 79(3):243-51. PubMed ID: 15896651
[TBL] [Abstract][Full Text] [Related]
25. Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy.
Yuan J; Mahama-Relue PA; Fournier RL; Hampton JA
Radiat Res; 1997 Oct; 148(4):386-94. PubMed ID: 9339955
[TBL] [Abstract][Full Text] [Related]
26. Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy.
Kruijt B; de Bruijn HS; van der Ploeg-van den Heuvel A; de Bruin RW; Sterenborg HJ; Amelink A; Robinson DJ
Photochem Photobiol; 2008; 84(6):1515-27. PubMed ID: 18557821
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
28. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.
Dysart JS; Patterson MS
Photochem Photobiol Sci; 2006 Jan; 5(1):73-81. PubMed ID: 16395430
[TBL] [Abstract][Full Text] [Related]
29. Optimizing the administrated light dose during 5-ALA-mediated photodynamic therapy: Murine 4T1 breast cancer model.
Amiri H; Mokhtari-Dizaji M; Mozdarani H
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12925. PubMed ID: 37968826
[TBL] [Abstract][Full Text] [Related]
30. Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources.
Togsverd-Bo K; Idorn LW; Philipsen PA; Wulf HC; Hædersdal M
Exp Dermatol; 2012 Oct; 21(10):745-50. PubMed ID: 22882358
[TBL] [Abstract][Full Text] [Related]
31. Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid.
Bissonnette R; Sharfaei S; Viau G; Liu Y
Br J Dermatol; 2004 Sep; 151(3):653-5. PubMed ID: 15377353
[TBL] [Abstract][Full Text] [Related]
32. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes.
Pudroma X; Juzeniene A; Ma LW; Iani V; Moan J
J Environ Pathol Toxicol Oncol; 2011; 30(3):235-40. PubMed ID: 22126616
[TBL] [Abstract][Full Text] [Related]
34. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
35. Spectroscopic measurements of photoinduced processes in human skin after topical application of the hexyl ester of 5-aminolevulinic acid.
Zhao L; Nielsen KP; Juzeniene A; Juzenas P; Lani V; Ma LW; Stamnes K; Stamnes JJ; Moan J
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):307-20. PubMed ID: 16566726
[TBL] [Abstract][Full Text] [Related]
36. The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
Blake E; Campbell S; Allen J; Mathew J; Helliwell P; Curnow A
J Photochem Photobiol B; 2012 Dec; 117():97-103. PubMed ID: 23092624
[TBL] [Abstract][Full Text] [Related]
37. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
[TBL] [Abstract][Full Text] [Related]
38. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin.
Van der Veen N; De Bruijn HS; Star WM
Int J Cancer; 1997 Jul; 72(1):110-8. PubMed ID: 9212231
[TBL] [Abstract][Full Text] [Related]
39. In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy.
Niedre MJ; Secord AJ; Patterson MS; Wilson BC
Cancer Res; 2003 Nov; 63(22):7986-94. PubMed ID: 14633731
[TBL] [Abstract][Full Text] [Related]
40. Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.
Mallidi S; Anbil S; Lee S; Manstein D; Elrington S; Kositratna G; Schoenfeld D; Pogue B; Davis SJ; Hasan T
J Biomed Opt; 2014 Feb; 19(2):028001. PubMed ID: 24503639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
